Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
OBJECTIVE
Identification of an association between IRF5 rs2004640 and systemic sclerosis (SSc) has highlighted a key role for type 1 interferon (IFN). Additional functional IRF5 variants have been identified as autoimmune susceptibility factors. Our aim was to investigate whether IRF5 haplotypes confer susceptibility to SSc, and to perform genotype haplotype-phenotype correlation analyses.


METHODS
We genotyped IRF5 rs377385, rs2004640, and rs10954213 in 1623 individuals of French European Caucasian origin. SSc patient subphenotypes were analyzed according to cutaneous subsets and for SSc-related pulmonary fibrosis.


RESULTS
Case-control studies of single markers revealed an association between IRF5 rs3757385, rs2004640, and rs10954213 variants and SSc. We identified an IRF5 risk haplotype "R" (p(adj) = 0.024, OR 1.23, 95% CI 1.07-1.40) and a mirrored protective haplotype "P" (p(adj) = 8.8 x 10(-3), OR 0.78, 95% CI 0.68-0.90) for SSc susceptibility. Genotype-phenotype correlation analyses failed to detect any association with a single marker. By contrast, phenotype-haplotype correlation analysis was able to detect intra-cohort association and to discriminate SSc patients with from those without the following clinical traits: "R" and/or "P" haplotypes identified diffuse cutaneous SSc (p = 0.0081) and fibrosing alveolitis (p = 0.018).


CONCLUSIONS
IRF5 haplotypes are more informative than single markers, suggesting that they could be helpful for risk stratification of SSc patients. Our study provides further evidence of a key role of IRF5 in SSc severity.
Dieude
Philippe
P
Service de Rhumatologie, Hôpital Bichat Claude Bernard, APHP, Université Diderot-Paris 7, Paris, France. philippe.dieude@bch.aphp.fr
Dawidowicz
Karen
K
Guedj
Mickaël
M
Legrain
Yona
Y
Wipff
Julien
J
Hachulla
Eric
E
Diot
Elisabeth
E
Sibilia
Jean
J
Mouthon
Luc
L
Cabane
Jean
J
Amoura
Zahir
Z
Crakowski
Jean-Luc
JL
Carpentier
Patrick
P
Avouac
Jerome
J
Meyer
Olivier
O
Kahan
Andre
A
Boileau
Catherine
C
Allanore
Yannick
Y
D001323:Autoantibodies / Q000235:genetics; D016022:Case-Control Studies; D005787:Gene Frequency; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006239:Haplotypes / Q000235:genetics*; D006801:Humans; D050835:Interferon Regulatory Factors / Q000235:genetics*; D016017:Odds Ratio; D010641:Phenotype; D016133:Polymerase Chain Reaction; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D012595:Scleroderma, Systemic / Q000235:genetics* / Q000503:physiopathology; D012720:Severity of Illness Index
D001323:Autoantibodies; C431713:IRF5 protein, human; D050835:Interferon Regulatory Factors